These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 2902018)
1. A new immunotoxin built by linking a hemolytic toxin to a monoclonal antibody specific for immature T lymphocytes. Avila AD; Mateo de Acosta C; Lage A Int J Cancer; 1988 Oct; 42(4):568-71. PubMed ID: 2902018 [TBL] [Abstract][Full Text] [Related]
2. A carcinoembryonic antigen-directed immunotoxin built by linking a monoclonal antibody to a hemolytic toxin. Avila AD; Mateo de Acosta C; Lage A Int J Cancer; 1989 May; 43(5):926-9. PubMed ID: 2785509 [TBL] [Abstract][Full Text] [Related]
3. Construction of an immunotoxin by linking a monoclonal antibody against the human epidermal growth factor receptor and a hemolytic toxin. Avila AD; Calderón CF; Pérez RM; Pons C; Pereda CM; Ortiz AR Biol Res; 2007; 40(2):173-83. PubMed ID: 18064354 [TBL] [Abstract][Full Text] [Related]
4. Construction of an immunotoxin with the pore forming protein StI and ior C5, a monoclonal antibody against a colon cancer cell line. Tejuca M; Díaz I; Figueredo R; Roque L; Pazos F; Martínez D; Iznaga-Escobar N; Pérez R; Alvarez C; Lanio ME Int Immunopharmacol; 2004 Jun; 4(6):731-44. PubMed ID: 15135315 [TBL] [Abstract][Full Text] [Related]
5. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo. Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688 [TBL] [Abstract][Full Text] [Related]
6. Selective killing of tumor cells in vitro by an immunotoxin composed of ricin and monoclonal antibody against Ia antigen. Wu M; Tang SL; Zang RJ; Yu H Int J Immunopharmacol; 1990; 12(2):235-9. PubMed ID: 2329015 [TBL] [Abstract][Full Text] [Related]
7. Mutations in diphtheria toxin separate binding from entry and amplify immunotoxin selectivity. Greenfield L; Johnson VG; Youle RJ Science; 1987 Oct; 238(4826):536-9. PubMed ID: 3498987 [TBL] [Abstract][Full Text] [Related]
8. Cytotoxic potential of anti-CD7 immunotoxin (WT1-ricin A) to purge ex vivo malignant T cells in bone marrow. Preijers FW; De Witte T; Wessels JM; Meyerink JP; Haanen C; Capel PJ Br J Haematol; 1989 Feb; 71(2):195-201. PubMed ID: 2784323 [TBL] [Abstract][Full Text] [Related]
9. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain. Ramakrishnan S; Houston LL Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765 [TBL] [Abstract][Full Text] [Related]
10. Rationale for immunotoxin therapy of metastatic prostate carcinoma formatted as a multi-stage delivery system. Webb KS; Poulton SH; Liberman SN; Walther PJ J Urol; 1989 Aug; 142(2 Pt 1):425-32. PubMed ID: 2787412 [TBL] [Abstract][Full Text] [Related]
11. Selective cytotoxic activity of immunotoxins composed of a monoclonal anti-Thy 1.1 antibody and the ribosome-inactivating proteins bryodin and momordin. Stirpe F; Wawrzynczak EJ; Brown AN; Knyba RE; Watson GJ; Barbieri L; Thorpe PE Br J Cancer; 1988 Nov; 58(5):558-61. PubMed ID: 3265330 [TBL] [Abstract][Full Text] [Related]
12. Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin. Zovickian J; Johnson VG; Youle RJ J Neurosurg; 1987 Jun; 66(6):850-61. PubMed ID: 3033171 [TBL] [Abstract][Full Text] [Related]
13. Gigantoxin-4-4D5 scFv is a novel recombinant immunotoxin with specific toxicity against HER2/neu-positive ovarian carcinoma cells. Lv X; Zhang J; Xu R; Dong Y; Sun A; Shen Y; Wei D Appl Microbiol Biotechnol; 2016 Jul; 100(14):6403-6413. PubMed ID: 27063011 [TBL] [Abstract][Full Text] [Related]
14. The Aspergillus toxin restriction is a suitable cytotoxic agent for generation of immunoconjugates with monoclonal antibodies directed against human carcinoma cells. Conde FP; Orlandi R; Canevari S; Mezzanzanica D; Ripamonti M; Muñoz SM; Jorge P; Colnaghi MI Eur J Biochem; 1989 Jan; 178(3):795-802. PubMed ID: 2783572 [TBL] [Abstract][Full Text] [Related]
15. Bispecific anti-CD22/anti-CD3-ricin A chain immunotoxin is cytotoxic to Daudi lymphoma cells but not T cells in vitro and shows both A-chain-mediated and LAK-T-mediated killing. Shen GL; Li JL; Vitetta ES J Immunol; 1994 Mar; 152(5):2368-76. PubMed ID: 8133047 [TBL] [Abstract][Full Text] [Related]
16. Intra-thecal treatment of leptomeningeal lymphoma with immunotoxin. Urch CE; George AJ; Stevenson GT; Bolognesi A; Stirpe F; Weller R; Glennie MJ Int J Cancer; 1991 Apr; 47(6):909-15. PubMed ID: 2010234 [TBL] [Abstract][Full Text] [Related]
18. Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies. Manzke O; Russello O; Leenen C; Diehl V; Bohlen H; Berthold F Med Pediatr Oncol; 2001 Jan; 36(1):185-9. PubMed ID: 11464879 [TBL] [Abstract][Full Text] [Related]
19. Successful treatment of human acute T-cell leukemia in SCID mice using the anti-CD7-deglycosylated ricin A-chain immunotoxin DA7. Jansen B; Vallera DA; Jaszcz WB; Nguyen D; Kersey JH Cancer Res; 1992 Mar; 52(5):1314-21. PubMed ID: 1371092 [TBL] [Abstract][Full Text] [Related]
20. [Preparation of SOKT1-RTA immunotoxin and its specific cytotoxic effect on human T lymphocytes]. Zhong W; Dai B Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(3):240-4. PubMed ID: 1748404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]